# PET Study Examining the Dopaminergic Activity of Armodafinil in Adults

> **NCT00592943** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** armodafinil

## Key facts

- **NCT ID:** NCT00592943
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-05
- **Final completion:** 2010-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592943, "PET Study Examining the Dopaminergic Activity of Armodafinil in Adults". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00592943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*